ViroPharma Denied Block On Generic Vancocin Approval

Law360, New York (January 09, 2013, 5:54 PM ET) -- A Washington federal judge on Wednesday ended ViroPharma Inc.'s bid to cancel the U.S. Food and Drug Administration's approval of generic versions of antibiotic Vancocin and extend its exclusive rights to the drug, saying the FDA had acted properly in approving the generics.

According to U.S. District Judge Ellen Segal Huvelle's order, denying ViroPharma's motion for summary judgment and granting the FDA's motion to dismiss the case, the FDA was well within its discretion to approve generic versions of the drug and deny the drugmaker an...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers